14-day Premium Trial Subscription Try For FreeTry Free
$1.50
+0.0100 (+0.671%)
At Close: Apr 24, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $1.24 $2.30 Wednesday, 24th Apr 2024 ATOS stock ended at $1.50. This is 0.671% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 7.77% from a day low at $1.48 to a day high of $1.60.
90 days $0.774 $2.30
52 weeks $0.590 $2.30

Historical Atossa Genetics Inc. prices

Date Open High Low Close Volume
Feb 18, 2021 $3.12 $3.26 $3.03 $3.11 9 105 194
Feb 17, 2021 $3.41 $3.42 $3.16 $3.29 12 219 384
Feb 16, 2021 $3.57 $3.62 $3.43 $3.48 10 055 050
Feb 12, 2021 $2.94 $3.78 $2.85 $3.64 31 422 401
Feb 11, 2021 $3.51 $3.51 $3.14 $3.19 18 948 962
Feb 10, 2021 $3.74 $3.75 $3.40 $3.48 20 962 220
Feb 09, 2021 $3.90 $3.91 $3.51 $3.74 18 750 585
Feb 08, 2021 $4.00 $4.02 $3.65 $3.86 20 284 501
Feb 05, 2021 $4.01 $4.10 $3.50 $3.89 37 850 140
Feb 04, 2021 $4.43 $4.90 $4.03 $4.33 124 225 319
Feb 03, 2021 $3.02 $3.28 $2.90 $3.25 51 676 654
Feb 02, 2021 $2.54 $3.19 $2.42 $2.80 76 668 261
Feb 01, 2021 $2.37 $2.43 $2.15 $2.37 19 862 892
Jan 29, 2021 $2.20 $2.28 $2.06 $2.21 17 406 268
Jan 28, 2021 $2.25 $2.45 $1.96 $2.08 23 411 386
Jan 27, 2021 $2.26 $2.65 $2.04 $2.22 44 906 080
Jan 26, 2021 $3.36 $3.77 $2.18 $2.61 149 398 839
Jan 25, 2021 $2.48 $3.00 $2.01 $2.98 99 160 279
Jan 22, 2021 $1.88 $1.95 $1.66 $1.87 40 071 389
Jan 21, 2021 $1.75 $2.06 $1.47 $1.67 61 340 745
Jan 20, 2021 $1.42 $1.55 $1.28 $1.54 21 233 609
Jan 19, 2021 $1.33 $1.45 $1.29 $1.41 17 170 146
Jan 15, 2021 $1.33 $1.33 $1.13 $1.25 15 462 679
Jan 14, 2021 $1.21 $1.35 $1.19 $1.25 24 679 327
Jan 13, 2021 $1.08 $1.24 $1.07 $1.18 24 125 411
Click to get the best stock tips daily for free!

About Atossa Genetics Inc.

Atossa Genetics Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patien... ATOS Profile

Golden Star

Ticker Date Change Price
MLI Apr 19 10.86% $52.28
LPLA Apr 19 0.743% $262.59
DOOR Apr 18 0.160% $131.39
LNG Apr 17 0.389% $156.81
FCN Apr 16 2.95% $207.62
ELV Apr 16 5.28% $506.97
DXC Apr 08 0.767% $20.87
AKR Apr 05 5.63% $16.53
ITCI Apr 05 6.84% $68.44
SARK Mar 28 13.80% $26.88
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT